Loading…
China SXT Pharmaceuticals, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in SXTC.
▼ -100.0% over 5Y.
today you would have $0.01▼ -100.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Year-end price | $2.57 | $19,200.00 | $6,096.00 | $47,640.00 | |
| P/S | 0.1x | 0.0x | 12.6x | 0.1x | 0.1x |
| P/B | 0.0x | 0.0x | 1.4x | 0.0x | 0.0x |
| EPS | — | -$2,882.77 | -$134,718.78 | -$1,483,693.00 | |
| Profit margin | -245.38% | -545.24% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BBLGBone Biologics Corp | $0.62 | — | 0.3x | — | -54.96% | $1.69M |
| SCNIScinai Immunotherapeutics Ltd. | $2.51 | 0.1x | 0.1x | — | -26.53% | $1.7M |
| AEMDAethlon Medical Inc | $2.49 | — | 0.2x | — | -160.91% | $1.77M |
| MNDRMobile-health Network Solutions | $1.55 |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Company description provided by Yahoo Finance.
| -189.77% |
| -160.67% |
| -301.00% |
| ROE | -21.82% | -20.89% | -21.40% | -22.24% | -40.40% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 0.1x |
| — |
| -47.59% |
| $1.85M |
| DCOYDecoy Therapeutics Inc. | $2.90 | 0.0x | 0.4x | — | -827.77% | $1.9M |
| CDTCDT Equity Inc. | $1.69 | — | 0.0x | — | -69.68% | $1.33M |